Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Long-Term Investments (2016)

Arcadia Biosciences (RKDA) has disclosed Long-Term Investments for 3 consecutive years, with $2.5 million as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Long-Term Investments fell 87.35% year-over-year to $2.5 million, compared with a TTM value of $2.5 million through Dec 2016, down 87.35%, and an annual FY2016 reading of $2.5 million, down 87.35% over the prior year.
  • Long-Term Investments was $2.5 million for Q4 2016 at Arcadia Biosciences, down from $3.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $19.7 million in Q4 2015 and bottomed at $500000.0 in Q4 2014.
  • Average Long-Term Investments over 3 years is $5.5 million, with a median of $2.5 million recorded in 2016.
  • The sharpest move saw Long-Term Investments soared 3849.6% in 2015, then crashed 87.35% in 2016.
  • Year by year, Long-Term Investments stood at $500000.0 in 2014, then skyrocketed by 3849.6% to $19.7 million in 2015, then plummeted by 87.35% to $2.5 million in 2016.
  • Business Quant data shows Long-Term Investments for RKDA at $2.5 million in Q4 2016, $3.5 million in Q3 2016, and $6.9 million in Q2 2016.